AIM ImmunoTech Inc.
AIMI
$0.0801
$0.012117.79%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -5.97M | -3.70M | -1.84M | -5.82M | -12.58M |
| Total Depreciation and Amortization | 64.00K | 63.00K | 61.00K | 58.00K | 58.00K |
| Total Amortization of Deferred Charges | 69.00K | -38.00K | 197.00K | 73.00K | -- |
| Total Other Non-Cash Items | 464.00K | 180.00K | 840.00K | 105.00K | 678.00K |
| Change in Net Operating Assets | 1.42M | 385.00K | -2.27M | 766.00K | 2.08M |
| Cash from Operations | -3.96M | -3.11M | -3.01M | -4.82M | -9.76M |
| Capital Expenditure | 0.00 | -18.00K | -- | -- | 10.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 47.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.70M | 352.00K | 826.00K | -158.00K | -271.00K |
| Cash from Investing | 3.70M | 334.00K | 826.00K | -158.00K | -214.00K |
| Total Debt Issued | 0.00 | 133.00K | -133.00K | 2.50M | -- |
| Total Debt Repaid | -251.00K | -- | -- | -- | -- |
| Issuance of Common Stock | 32.00K | 4.00K | 527.00K | 329.00K | 147.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.26M | 0.00 | 2.05M | -- | -- |
| Cash from Financing | 1.04M | 137.00K | 2.44M | 2.83M | 147.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 786.00K | -2.64M | 259.00K | -2.14M | -9.83M |